Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-659 Combination therapy in Subjects with Cystic Fibrosis who are Homozygous or Heterozygous for the F508del Mutation.
Keating, Dominic
(Primary Chief Investigator (PCI))
Medicine Alfred Hospital
Central Clinical School Clinical Trials
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
10/08/18
→
10/08/23
View all
View less